| PBCJX | VIGAX | PBCJX / VIGAX | |
| Total Expense Ratio | 0.77 | 0.05 | 1,540% |
| Annual Report Gross Expense Ratio | 0.80 | 0.05 | 1,600% |
| Fund Existence | 8 years | 25 years | - |
| Gain YTD | -8.186 | 20.609 | -40% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.91B | 353B | 3% |
| Annual Yield % from dividends | 0.00 | 0.41 | - |
| Returns for 1 year | -10.52 | 16.35 | -64% |
| Returns for 3 years | 50.22 | 134.43 | 37% |
| Returns for 5 years | 21.88 | 97.14 | 23% |
| Returns for 10 years | N/A | 359.16 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SGQAX | 44.95 | 0.05 | +0.11% |
| DWS International Opportunities A | |||
| CICCX | 62.89 | 0.03 | +0.05% |
| American Funds Invmt Co of Amer 529C | |||
| NEFSX | 48.28 | N/A | N/A |
| Natixis US Equity Opportunities A | |||
| QALGX | 38.91 | N/A | N/A |
| Federated Hermes MDT Large Cap Growth A | |||
| GMVAX | 16.66 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Equity A | |||